World First T-Rex Leather™ Product
RNS Number : 1576Z BSF Enterprise PLC 02 April 2026 2 April 2026 BSF Enterprise PLC Unveiling of World's First T-Rex Leather™ Product and Commercialisation Roadmap BSF Enterprise PLC (LSE: BSFA; OTCQB: BSFAF), a leader in the field of lab-grown tissues and sustainable biotechnology, is pleased to announce the unveiling of the world's first product made from lab-grown T-Rex Leather™ via its wholly owned subsidiary Lab-Grown Leather Ltd The product, a one-of-a-kind luxury handbag designed by the avant-garde techwear label Enfin Levé, will be debuted today at the Art Zoo Museum in Amsterdam. The unveiling marks a significant milestone for BSF's wholly owned subsidiary, Lab-Grown Leather Ltd., demonstrating the successful application of its proprietary tissue engineering technology to extinct protein sequences. Technological Breakthrough T-Rex Leather™, an LGL proprietary material forming part of its Elemental Leather™ range, was developed through a unique scientific collaboration between Lab-Grown Leather Ltd., The Organoid Company, with the marketing support of creative agency VML. ● Reconstruction: Scientists used AI-driven computational modelling to reconstruct complete collagen blueprints from fossilised T.rex sequences. Collagen being the principal structural element preserved in skin during the formation of leather. ● Cultivation: Using Lab-Grown Leather's Advanced Tissue Engineering Platform (ATEP™), which underpins Elemental Leather™, billions of engineered cells were cultivated to create a uniquely novel material based upon predicted prehistoric genomic information. This innovative platform facilitates the production of a new class of bio-material, offering unique aesthetics and feel not seen for 68 million years, whilst retaining structural properties found in traditional leather but without the need for animal slaughter or synthetic scaffolds. ● Sustainability: The resulting biomaterial is durable, repairable, biodegradable, and compatible with existing leather finishing techniques. Commercialisation and Market Strategy While the initial handbag serves as a high-profile proof-of-concept, the Company intends to scale the underlying technology across multiple high-value sectors: ● Luxury Fashion: T-Rex Leather™ will be made commercially available to premium brands and designers for use in luxury accessories. ● Automotive & Performance: Long-term ambitions include providing high-performance, slaughter-free interiors for the automotive sector and other high-performance material markets. ● Market Opportunity: The Company is positioning its core product Elemental Leather™ portfolio to capture share in the $60 billion luxury leather market and the $20 billion bio-based materials market. Upcoming Auction Following a six-week exhibition at the Art Zoo Museum, the one-of-a-kind T-Rex Leather™ handbag will be sold to the highest bidder. The Company expects the auction to be conducted via a major international auction house later this year. Further details regarding the auction partner and date will be released in due course. Dr Che Connon, commented: "By collaborating with VML and The Organoid Company, we're unlocking the potential to engineer leather from prehistoric species. This venture showcases the power of cell-based technology to create materials that are both innovative and ethically sound, paving the way for commercially attractive improvements in unique character and cost-efficiency". END Engage with the BSF Enterprise management team directly by asking questions, watching video summaries and seeing what other shareholders have to say. Navigate to our Interactive Investor website here: https://bsfenterprise.com/about For further enquiries, please visit www.bsfenterprise.com or contact:
| BSF Enterprise PLC Geoff Baker - Chairman Che Connon - CEO & Director We encourage all investors to share questions on this announcement via our investor website. | https://bsfenterprise.com/s/a1f22b |
| Shard Capital (Broker) Damon Heath Isabella Pierre | (0)20 4530 6926 (0)20 4530 6928 |
| Bowsprit Partners John Treacy James Sheehan | +44 (0)203 883 4430 |
| ISIN of the Ordinary Shares is GB00BHNBDQ51. SEDOL Code is BHNBDQ5. |